PREVIOUS
✖
TNPSC BITS
July 8 , 2021
1199 days
866
0
- Hyderabad-based pharma player Laurus Labs has received a licence for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India.
- The licence to Laurus Labs has been granted by DRDO.
- Panacea Biotec received its licence from the Drugs Controller General of India to manufacture Sputnik V COVID-19 vaccine at its facility in Baddi, Himachal Pradesh.
- New Delhi-based Panacea Biotech is in collaboration with the Russian Direct Investment.
Leave a Reply
Your Comment is awaiting moderation.